Prevention benefits of repeated acute treatment with rimegepant 75 mg-Simulation model validated by an open label safety study (BHV3000-201)
HEADACHE（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined